제13회 서울국제신약포럼 > Forum & Conference

본문 바로가기

파이낸셜뉴스 부산파이낸셜뉴스 블록포스트 가이드포스트 fn아이포커스 파이낸셜뉴스재팬 fnMICE fn이노에듀 fn투어


지난행사목록

본문

 

 

 

Introduction

 

 

K-Bio fever continues to be strong this year. From early this year, domestic pharmaceutical and 

biopharma companies have successfully developed new drugs and exported related technologies. 

They develop new drugs through open-innovation and export not only novel medicines and but also

the platform technologies, raising the status of Korean bioproducts in the world.

 

Against this backdrop, pharmaceutical and biopharma companies will mobilize 10 trillion won by 2023 to promote 

bio and health sectors, which are considered the next-generation core industries. The government, by expanding 

the bio-and-health-related R&D budget by 30%, actively supporting the boom in the bio industry.

 

One area that is garnering attention in the pharmaceutical industry is the platform technologies, which have 

the potential to be the foundation of new drug development. The next-generation drug development platforms 

not only raise the possibility of successful identification of drug candidates but are becoming the original technology 

that increases the diversity and efficiency in developing new molecules.

 

Thus, the R&D investment on new drug development is escalating across the globe, and platform technologies 

are rising as a new growth engine for pharma and biopharma companies. It was also applied in developing 

the COVID-19 vaccine recently.

 

Utilizing technologies like artificial intelligence, big data, organoid and 3D-printing, the platform technology 

is the core driver in improving efficiency in drug development process. Thus, the application of this technology 

can reduce time and cost in novel drug research and development, and it can enable the development of 

other new drugs from one molecule and open the opportunity for pharmaceutical firms to out-license drugs.

 

As such, the Financial News is hosting the 13th Seoul International New Pharmaceuticals Forum as a venue 

to discuss new opportunities platform technologies provide in drug development with the experts and representatives 

from related organizations. 

 

 

 

Overview

 

 

Title : ​The 13th Seoul International New Pharmaceuticals Forum


Theme : Transition in the New Drug Development Platforms


Date : ​June 17th, 2021(Thu) 09:00~12:00


Venue : ​Orchid, The Westin Josun Seoul Hotel


Hosts : ​The Financial News,

           Korea Research Institute of Chemical Technology

 

Sponsors : Ministry of Health and Welfare, Ministry of Science and ICT, 

       Ministry of Trade, Industry and Energy,

       Ministry of Food and Drug Safety, 

       Korea Pharmaceutical and Bio-Pharma Manufacturers Association, 

       Korea Biotechnology Industry Organization,

       Korea Research-based Pharma Industry Association


Contact : Seoul International New Pharmaceuticals Forum Bureau

     Tel. 02-6965-0026  

     Mail. cayley@fnmice.com


 

첨부파일

서울특별시 서초구 강남대로 315, 파이낸셜뉴스빌딩 9층 | TEL. 02-6965-0016 | FAX. 02-6965-0000 | E-mail : info@fnmice.com
Copyright (c) fnMICE. All rights reserved.